These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31624109)

  • 21. Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System.
    Scharff BFSS; Modvig S; Marquart HV; Christensen C
    Front Oncol; 2020; 10():775. PubMed ID: 32528884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxicity due to central nervous system therapy for childhood leukemia.
    Ochs JJ
    Am J Pediatr Hematol Oncol; 1989; 11(1):93-105. PubMed ID: 2653080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin.
    Gunther R; Chelstrom LM; Tuel-Ahlgren L; Simon J; Myers DE; Uckun FM
    Blood; 1995 May; 85(9):2537-45. PubMed ID: 7537120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia.
    Maki H; Yoshimi A; Shimada T; Arai S; Morita K; Kamikubo Y; Ikegawa M; Kurokawa M
    Exp Hematol; 2021 Feb; 94():31-36. PubMed ID: 33453340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
    Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
    J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.
    Morra E; Lazzarino M; Brusamolino E; Pagnucco G; Castagnola C; Bernasconi P; Orlandi E; Corso A; Santagostino A; Bernasconi C
    Cancer; 1993 Jul; 72(2):439-45. PubMed ID: 8319175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
    Thomas X; Pavan L; Le QH
    Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
    Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
    Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
    [No Abstract]   [Full Text] [Related]  

  • 31. Current pharmacological treatment approaches to central nervous system leukaemia.
    Blaney SM; Balis FM; Poplack DG
    Drugs; 1991 May; 41(5):702-16. PubMed ID: 1712705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review.
    Fajardo-Orduña GR; Ledesma-Martínez E; Aguiñiga-Sánchez I; Mora-García ML; Weiss-Steider B; Santiago-Osorio E
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of microenvironment and immunity in drug response in leukemia.
    Bakker E; Qattan M; Mutti L; Demonacos C; Krstic-Demonacos M
    Biochim Biophys Acta; 2016 Mar; 1863(3):414-426. PubMed ID: 26255027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib.
    Kondo T; Tasaka T; Matsumoto K; Matsumoto R; Koresawa L; Sano F; Tokunaga H; Matsuhashi Y; Nakanishi H; Morita K; Wada H; Sugihara T
    Springerplus; 2014; 3():177. PubMed ID: 24790822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data.
    Lenk L; Alsadeq A; Schewe DM
    Cancer Metastasis Rev; 2020 Mar; 39(1):173-187. PubMed ID: 31970588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.
    Akers SM; Rellick SL; Fortney JE; Gibson LF
    Leuk Res; 2011 Jun; 35(6):705-11. PubMed ID: 21269691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A three-dimensional
    Bray LJ; Binner M; Körner Y; von Bonin M; Bornhäuser M; Werner C
    Haematologica; 2017 Jul; 102(7):1215-1226. PubMed ID: 28360147
    [No Abstract]   [Full Text] [Related]  

  • 40. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
    Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
    Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.